ImmunityBio, Inc. SEC filings IBRX
ImmunityBio, Inc. has 554 filings in SEC EDGAR's recent list, going back to Apr 29, 2005. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Dec 29, 2025 | — |
| 424B5 | Prospectus supplement | Jul 28, 2025 | — |
| S-8 | Employee stock plan registration | Jun 23, 2025 | — |
| 424B5 | Prospectus supplement | Apr 8, 2025 | — |
| 424B5 | Prospectus supplement | Dec 12, 2024 | — |
| 424B5 | Prospectus supplement | Dec 10, 2024 | — |
| S-8 | Employee stock plan registration | Jun 20, 2024 | — |
| S-3ASR | Automatic shelf registration | Apr 17, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| 424B5 | Prospectus supplement | Jul 25, 2023 | — |
| 424B5 | Prospectus supplement | Jul 24, 2023 | — |
| 424B5 | Prospectus supplement | Feb 16, 2023 | — |
| S-3 | Shelf registration | Feb 7, 2023 | — |
| 424B5 | Prospectus supplement | Dec 12, 2022 | — |
| S-3MEF | Filing | Dec 12, 2022 | — |
| 424B5 | Prospectus supplement | Dec 12, 2022 | — |
| S-8 | Employee stock plan registration | Jun 14, 2022 | — |
| 424B5 | Prospectus supplement | May 26, 2022 | — |
| S-3/A | Filing | May 16, 2022 | — |
| POS AM | Filing | Mar 7, 2022 | — |
| S-8 POS | Filing | May 21, 2021 | — |
| POS AM | Filing | May 21, 2021 | — |
| 424B5 | Prospectus supplement | May 3, 2021 | — |
| S-3ASR | Automatic shelf registration | Apr 30, 2021 | — |
| 424B3 | Prospectus | Feb 2, 2021 | — |
| S-4/A | Filing | Jan 29, 2021 | — |
| S-4 | Registration for a merger or exchange | Jan 19, 2021 | — |
| S-8 | Employee stock plan registration | Aug 10, 2020 | — |
| 424B5 | Prospectus supplement | Jun 25, 2020 | — |
| 424B5 | Prospectus supplement | Jun 24, 2020 | — |
| S-3 | Shelf registration | Aug 23, 2019 | — |
| S-8 | Employee stock plan registration | Aug 7, 2019 | — |
| S-3 | Shelf registration | Aug 17, 2016 | — |
| S-8 | Employee stock plan registration | Jul 30, 2015 | — |
| 424B4 | Prospectus | Jul 29, 2015 | — |
| S-1MEF | Filing | Jul 27, 2015 | — |
| S-1/A | Amended registration statement | Jul 27, 2015 | — |
| S-1/A | Amended registration statement | Jul 27, 2015 | — |
| S-1/A | Amended registration statement | Jul 16, 2015 | — |
| S-1/A | Amended registration statement | Jul 15, 2015 | — |
| S-1/A | Amended registration statement | Jul 13, 2015 | — |
| S-1/A | Amended registration statement | Jul 2, 2015 | — |
| S-1 | Registration statement | Jun 19, 2015 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IBRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1326110
- Former names
- NantKwest, Inc. (until Mar 8, 2021); Conkwest, Inc. (until Jul 13, 2015); ZelleRx Corp (until Oct 9, 2009)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.